Asharam Tamang v. HHS - Tdap, adhesive capsulitis (2016)

Filed 2015-12-10Decided 2016-08-04Vaccine Tdap
compensated$96,223

Case summary [AI summaries can sometimes make mistakes]

Asharam Tamang filed a petition for compensation under the National Vaccine Injury Compensation Program, alleging that he suffered cellulitis and adhesive capsulitis as a result of a Tetanus-diphtheria-acellular pertussis (Tdap) vaccination he received on April 23, 2013. The case was assigned to the Special Processing Unit.

The respondent filed a Rule 4(c) report conceding that Mr. Tamang was entitled to compensation for adhesive capsulitis, although arguing that the cellulitis did not meet the duration requirement.

Mr. Tamang agreed with the respondent's assessment.

A ruling on entitlement was issued on December 10, 2015, finding Mr. Tamang entitled to compensation for his adhesive capsulitis.

Subsequently, on June 17, 2016, the respondent filed a proffer of damages, proposing an award of $85,000.00 for pain and suffering and $11,223.27 for past unreimbursed expenses, totaling $96,223.27. Mr.

Tamang agreed with this proffered award. The decision on August 4, 2016, awarded Mr.

Tamang a lump sum payment of $96,223.27, representing compensation for actual and projected pain and suffering and past unreimbursed expenses.

Source PDFs 3 total · 2 downloaded